Single cell analysis of Crohn’s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties

Abstract

BackgroundIntestinal stem cells (ISCs) play indispensable roles in the maintenance of homeostasis, and also in the regeneration of the damaged intestinal epithelia. However, whether the inflammatory environment of Crohn’s disease (CD) affects properties of resident small intestinal stem cells remain uncertain.MethodsCD patient-derived small intestinal organoids were established from enteroscopic biopsy specimens taken from active lesions (aCD-SIO), or from mucosa under remission (rCD-SIO). Expression of ISC-marker genes in those organoids was examined by immunohistochemistry, and also by microfluid-based single-cell multiplex gene expression analysis. The ISC-specific function of organoid cells was evaluated using a single-cell organoid reformation assay.ResultsISC-marker genes, OLFM4 and SLC12A2, were expressed by an increased number of small intestinal epithelial cells in the active lesion of CD. aCD-SIOs, rCD-SIOs or those of non-IBD controls (NI-SIOs) were successfully established from 9 patients. Immunohistochemistry showed a comparable level of OLFM4 and SLC12A2 expression in all organoids. Single-cell gene expression data of 12 ISC-markers were acquired from a total of 1215 cells. t-distributed stochastic neighbor embedding analysis identified clusters of candidate ISCs, and also revealed a distinct expression pattern of SMOC2 and LGR5 in ISC-cluster classified cells derived from aCD-SIOs. Single-cell organoid reformation assays showed significantly higher reformation efficiency by the cells of the aCD-SIOs compared with that of cells from NI-SIOs.ConclusionsaCD-SIOs harbor ISCs with modified marker expression profiles, and also with high organoid reformation ability. Results suggest modification of small intestinal stem cell properties by unidentified factors in the inflammatory environment of CD.Electronic supplementary materialThe online version of this article (10.1007/s00535-018-1437-3) contains supplementary material, which is available to authorized users.

Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review

“…Single-cell analysis of small-bowel organoids derived from patients with Crohn’s disease show similar findings, with factors in the inflammatory microenvironment modifying intestinal stem cells. 89 Coculturing of macrophages and organoids have produced physiologic models recapitulating the epithelial-to-mesenchymal transition that occurs with fibrosis in Crohn’s disease and leukocyte migration. 90 , 91 Other groups have used epithelial organoids to determine epithelial barrier responses to interferon-γ-induced permeability changes.…”

Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides

“…Once formed, the structure of the organoid resembles normal intestinal epithelium, comprising of multiple crypt-like domains that contains villi, Paneth cells, goblet cells, and enterocytes (Sato et al, 2009;Yin et al, 2014). With proper maintenance, both types of intestinal organoids can retain the gene expression profile, function, and pathological characteristics of the normal intestine and have the ability to selfrenewal, even after many passages (Sato et al, 2009;Middendorp et al, 2014;Suzuki et al, 2018). A 3D organoid can capture patient-specific in vivo-like complexity and architecture, making it an ideal model to study the mechanisms of tissue homeostasis and disease development for diseases such as ulcerative colitis or colorectal cancer (Otte et al, 2004).…”

Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases

“…Intestinal enteroids/organoids faithfully retain the physiological and pathological features from intestinal segment of origin[25,27]. Previous studies showed that intestinal enteroids/organoids retain the tissue specific (region-specific, age-specific, and disease-specific) transcriptional and epigenetic profiles which might be programmed within ISCs.…”

“…Compared with non-IBD subjects, intestinal enteroids/organoids generated from UC patients showed different gene expression profiles (genes associated with antimicrobial defense, secretory and absorptive functions) which are possibly due to permanent changes in ISCs[14]. Moreover, ISCs derived from active CD patients revealed a distinct gene expression pattern of ISC markers (LGR5 and SMOC2)[27]. In a recent study, Howell et al identified that IECs from children with CD or UC showed specific changes in DNA methylation and transcription which were stable over time and were partly retained in intestinal enteroid/organoid cultures[28].…”

“…Recently, several studies have compared the profiles of gene expression and DNA methylation in intestinal enteroids/organoids derived from control and IBD patients[14,27,28]. A group of genes were differentially regulated in the intestinal enteroids/organoids of UC patients, including genes associated with antimicrobial defense (LYZ, PLA2G2A) and with mucus secretory functions (ZG16, CLCA1) compared with intestinal enteroids/organoids of non-IBD subjects[14].…”